Individualized treatment with sunitinib versus standard dosing with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Basappa, Naveen S
  • Lalani, Aly-Khan
  • Kalirai, Austin
  • Li, Haocheng
  • Wood, Lori
  • Kollmannsberger, Christian K
  • Sim, Hao-Wen
  • Kapoor, Anil
  • Hotte, Sebastien
  • Czaykowski, Piotr
  • Canil, Christina M
  • Reaume, M Neil
  • Bjarnason, Georg A
  • Vanhuyse, Marie
  • Soulieres, Denis
  • North, Scott A
  • Heng, Daniel Yick Chin

publication date

  • May 20, 2017